Immune to Cancer: The CRI Blog
-
AACR17 Update: Checkpoints, Vaccines, and the Power of Prediction
Day 3 at AACR17 highlighted the importance of immune memory and personalized approaches…
-
AACR17 Update: CAR T Cells, Regulatory T Cells, and the Future of Immunotherapy
Day two addressed several strategies to improve immunotherapy’s precision and effectiveness
-
AACR17 Update: Taking Immunotherapy to the Next Level
After cancer immunotherapy’s initial successes, new challenges are being confronted
-
AACR17: Immunotherapy’s Impact on the Future of Cancer Treatment
Dozens of CRI scientists to highlight the latest immunotherapy breakthroughs during five-day conference in nation’s capital.
-
#AACR16 Update: Vice President Biden and the National Cancer Moonshot Initiative
VP Biden addresses AACR16 seeking suggestions and solutions.
-
#AACR16 Update: The Promise of Synthetic Biology and CAR T Cell Technologies
Genetically engineered cells can be customized to target cancer.
-
#AACR16 Update: New Hope for Patients with Rare Skin Cancer, Head & Neck Cancer
Anti-PD-1 blockade and two other types of immunotherapy effective in treating multiple tumor types.
-
#AACR16 Update: The Cancer Research Institute’s Impact on Immunotherapy
Since our founding in 1953, the Cancer Research Institute has pioneered the field of cancer immunology, and… -
#AACR16 Update: How Immune Infiltration Predicts Survival in Cancer Patients
The Immunoscore is the strongest prognostic marker in colorectal cancer.